World Leaders in pMDI Product Development

No. 1 in MDI Product Development Services

OzUK is the leading contract research organisation specialising in the development, reformulation and commercialisation of pressurised metered dose inhaler (MDI) and liquid aerosol medicines

MDISprint™

Your FastTrack to Commercialisation

About MDISprint™

MDISprint streamlines the commercialization of Metered Dose Inhaler (MDI) products through a lean methodology that optimizes product development processes. This involves concurrent execution of Chemistry, Manufacturing, and Controls (CMC) modules, minimizing interdependencies and expediting time-to-market. The comprehensive approach includes strategic collaborations for component selection, CDMO support for commercial scale manufacturing, engagement with CROs for clinical trials, and partnerships with GMP manufacturers, ensuring end-to-end services and positioning clients for success in the competitive pharmaceutical market.

OzUKPartners

Working with Leaders to get you to market faster

Our corporate sponsors, comprising esteemed MDI component suppliers and trusted CDMOs, are integral to our mission of fast-tracking product development. Their expertise and support not only accelerate the process but also ensure the delivery of high-quality, market-ready solutions.

OzUKThinkSpace

Our Latest Insights

OzUKNews